PL2066340T3 - Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne z takich bakteryn poddanych obróbce cieplnej - Google Patents

Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne z takich bakteryn poddanych obróbce cieplnej

Info

Publication number
PL2066340T3
PL2066340T3 PL07804880T PL07804880T PL2066340T3 PL 2066340 T3 PL2066340 T3 PL 2066340T3 PL 07804880 T PL07804880 T PL 07804880T PL 07804880 T PL07804880 T PL 07804880T PL 2066340 T3 PL2066340 T3 PL 2066340T3
Authority
PL
Poland
Prior art keywords
heat treated
treated bacterins
bacterins
vaccines prepared
emulsion vaccines
Prior art date
Application number
PL07804880T
Other languages
English (en)
Inventor
Mark Davis Goodyear
Michael John Huether
Ramasamy Mannar Mannan
Nancee Lois Oien
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PL2066340T3 publication Critical patent/PL2066340T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL07804880T 2006-09-11 2007-08-30 Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne z takich bakteryn poddanych obróbce cieplnej PL2066340T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84366506P 2006-09-11 2006-09-11
EP07804880.8A EP2066340B1 (en) 2006-09-11 2007-08-30 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
PCT/IB2007/002553 WO2008032158A2 (en) 2006-09-11 2007-08-30 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins

Publications (1)

Publication Number Publication Date
PL2066340T3 true PL2066340T3 (pl) 2013-12-31

Family

ID=39110574

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07804880T PL2066340T3 (pl) 2006-09-11 2007-08-30 Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne z takich bakteryn poddanych obróbce cieplnej
PL11173797T PL2377550T3 (pl) 2006-09-11 2007-08-30 Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne wytworzone z takich bakteryn poddanych obróbce cieplnej

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11173797T PL2377550T3 (pl) 2006-09-11 2007-08-30 Bakteryny poddane obróbce cieplnej oraz szczepionki emulsyjne wytworzone z takich bakteryn poddanych obróbce cieplnej

Country Status (26)

Country Link
US (1) US8491915B2 (pl)
EP (2) EP2066340B1 (pl)
JP (2) JP5550341B2 (pl)
KR (1) KR101238486B1 (pl)
CN (1) CN101516393B (pl)
AR (1) AR062758A1 (pl)
AU (1) AU2007297287B2 (pl)
BR (1) BRPI0716548B1 (pl)
CA (1) CA2663166C (pl)
CL (1) CL2007002621A1 (pl)
CO (1) CO6160333A2 (pl)
DK (2) DK2066340T3 (pl)
ES (2) ES2535977T3 (pl)
ME (1) ME00598B (pl)
MX (1) MX2009001849A (pl)
NO (1) NO339147B1 (pl)
NZ (2) NZ574896A (pl)
PL (2) PL2066340T3 (pl)
PT (1) PT2066340E (pl)
RS (1) RS54981B1 (pl)
RU (2) RU2425692C2 (pl)
SI (1) SI2066340T1 (pl)
TW (1) TWI361077B (pl)
UA (1) UA98115C2 (pl)
WO (1) WO2008032158A2 (pl)
ZA (1) ZA200902493B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2440137C1 (ru) * 2007-12-21 2012-01-20 Пфайзер Инк. Термообработанные бактерины и эмульсионные вакцины, полученные из таких термообработанных бактеринов
EP2717055A1 (en) * 2012-10-04 2014-04-09 Institut Pasteur Use of Leptospira fainei serovar Hurstbridge bacteria for diagnosing leptospirosis
WO2021242279A1 (en) * 2020-05-26 2021-12-02 Cyrus 21St Century Entrpreneurship Llc Hakim pour cina's gand zoda-e

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721169A1 (de) * 1986-06-30 1988-01-14 Lion Corp Orale zubereitung
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
RU2030915C1 (ru) * 1990-10-31 1995-03-20 Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов Вакцина против лептоспироза животных
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
AU2001234616A1 (en) 2000-01-31 2001-08-07 Vic Jira Vaccine composition, process and methods
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
NZ538394A (en) 2002-08-26 2008-06-30 Pfizer Prod Inc Vaccine for respiratory and reproductive system infections in cattles
AU2003270779A1 (en) 2002-09-20 2004-04-08 The United States Of America As Represented By The Secretary Of Agriculture Vaccine compositions and adjuvant
AU2002951692A0 (en) 2002-09-23 2002-10-17 Vital Biotech (Hong Kong) Limited Improvements in or relating to vaccines
HRP20050660A2 (en) * 2003-01-29 2006-02-28 Pfizer Products Inc. Canine vaccines against bordetella bronchiseptica
AU2004226591B2 (en) * 2003-04-04 2009-06-04 Zoetis Services Llc Microfluidized oil-in-water emulsions and vaccine compositions

Also Published As

Publication number Publication date
BRPI0716548B1 (pt) 2020-10-06
ES2535977T3 (es) 2015-05-19
EP2066340B1 (en) 2013-07-31
CN101516393B (zh) 2014-05-14
RU2425692C2 (ru) 2011-08-10
DK2066340T3 (da) 2013-10-14
DK2377550T3 (en) 2015-04-07
EP2066340A2 (en) 2009-06-10
MX2009001849A (es) 2009-03-02
HK1130202A1 (en) 2009-12-24
NO339147B1 (no) 2016-11-14
RU2569457C2 (ru) 2015-11-27
MEP7509A (en) 2011-12-20
NO20090745L (no) 2009-03-11
AU2007297287B2 (en) 2013-03-14
PL2377550T3 (pl) 2015-07-31
RS54981B1 (sr) 2016-11-30
CL2007002621A1 (es) 2008-03-14
JP2010502238A (ja) 2010-01-28
UA98115C2 (ru) 2012-04-25
CN101516393A (zh) 2009-08-26
ES2432392T3 (es) 2013-12-03
KR101238486B1 (ko) 2013-03-04
CO6160333A2 (es) 2010-05-20
ME00598B (me) 2011-12-20
BRPI0716548A2 (pt) 2013-09-24
TW200820990A (en) 2008-05-16
TWI361077B (en) 2012-04-01
CA2663166C (en) 2015-11-03
EP2377550B1 (en) 2015-03-04
PT2066340E (pt) 2013-10-30
JP2014088428A (ja) 2014-05-15
SI2066340T1 (sl) 2013-11-29
NZ574896A (en) 2011-11-25
JP5550341B2 (ja) 2014-07-16
US8491915B2 (en) 2013-07-23
NZ595748A (en) 2013-07-26
AU2007297287A1 (en) 2008-03-20
KR20090039840A (ko) 2009-04-22
RU2009108004A (ru) 2010-10-20
US20080112970A1 (en) 2008-05-15
CA2663166A1 (en) 2008-03-20
WO2008032158A3 (en) 2008-07-03
WO2008032158A2 (en) 2008-03-20
JP5643906B2 (ja) 2014-12-17
EP2377550A1 (en) 2011-10-19
ZA200902493B (en) 2010-03-31
AR062758A1 (es) 2008-12-03
RS20090088A (sr) 2010-06-30
RU2011115400A (ru) 2012-10-27

Similar Documents

Publication Publication Date Title
ZA201005178B (en) Heat treated bacterins,and emulsion vaccines prepared from such heat treated bacterins
PL1901584T3 (pl) Grzejnik, urządzenie oraz sposób z nim powiązany
GB2454149B (en) Refuge chamber and method
PL2578081T4 (pl) Kompozycje, sposoby i urządzenia do leczenia chorób wątroby
BRPI0719855A2 (pt) método para transferência de calor e dispositivo para tal.
IL193397A0 (en) Hpv antigens, vaccine compositions, and related methods
EP2145949A4 (en) DEVICE AND METHOD FOR CONTROLLING TEMPERATURE
IL193643A0 (en) Metal heat treating methods and devices
EP2133584A4 (en) CLUTCH CONTROL DEVICE, AND CLUTCH CONTROL METHOD
GB0723711D0 (en) Heat recovery system and method
EP2090343A4 (en) DEVICE, METHOD AND GAME PROGRAM
EP2155239A4 (en) METHOD FOR REDUCING IMMUNE RESPONSE AND TREATMENT OF IMMUNE DISEASES
TWI371777B (en) Heat treatment unit, heat treatment method, and computer-readable recording medium
EP1934536A4 (en) THERMOELECTRIC HEAT PUMP FOR VENTILATION OF HEAT AND ENERGY RECOVERY
ZA200902493B (en) Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
GB0511702D0 (en) Heating apparatus and method
GB0607562D0 (en) Method, composition and use
TWI339936B (en) Fan system and starting method thereof
PL1842931T3 (pl) Sposób obróbki cieplnej
PL381254A1 (pl) Sposób oświetlania i/lub ogrzewania, urządzenie do oświetlania i/lub ogrzewania, zestaw do oświetlania i/lub ogrzewania
IL180387A0 (en) Item authentication system and method
SI1996705T1 (sl) Ekspresijo povečevalni DNA fragmenti, njihova uporaba in postopki za njihovo odkrivanje
AP2006003529A0 (en) Heating mixture and apparatus.
TWI317637B (en) Vaccine and manufacture method thereof
PL379394A1 (pl) Sposób ogrzewania zewnętrznych powierzchni, zwłaszcza poziomych i urządzenie do korzystania z tego sposobu